Study of LX1031 in Subjects With Non-Constipating Irritable Bowel Syndrome

PHASE2CompletedINTERVENTIONAL
Enrollment

155

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

July 31, 2009

Study Completion Date

August 31, 2010

Conditions
Irritable Bowel Syndrome
Interventions
DRUG

LX1031 High Dose

A high dose of LX1031; daily oral intake for 28 days

DRUG

LX1031 Low Dose

A low dose of LX1031; daily oral intake for 28 days.

DRUG

Placebo

Matching placebo dosing with daily oral intake

Trial Locations (36)

11021

Long Island Clinical Research, Great Neck

23502

National Clinical Research Norfolk Inc., Norfolk

27103

Piedmont Medical Associates, Winston-Salem

27108

Medoff Medical/Vital re:Search, Greensboro

27518

Cary Medical Research, Cary

27599

The UNC Center for Functional GI & Motility Disorders, Chapel Hill

28601

Unifour Medical Research, Hickory

29455

Coastal Carolina Research Center in Goose Creek, Goose Creek

30281

Clinical Research Atlanta, Stockbridge

32129

Accord Clinical Research, LLC, Port Orange

33010

Research Consultants Group, Hialeah

33426

Consultants for Clinical Research of S. Florida, Boynton Beach

33486

Clinical Trials Management of Boca Raton, Inc., Boca Raton

37404

ClinSearch, Chattanooga

45219

Consultants for Clinical Research, Cincinnati

45242

Gastroenterology Research Consultant of Greater Cincinnati, Cincinnati

53186

Aurora Health Center - Waukesha, Waukesha

55905

Mayo Clinic, Rochester

72120

Arkansas Gastroenterology, Sherwood

73104

Oklahoma Foundation for Digestive Research, Oklahoma City

73112

Lynn Health Science Institute, Oklahoma City

77036

Pioneer Research Solutions, Houston

77090

Houston Medical Research Associates, Houston

80909

Lynn Instiute of the Rockies, Colorado Springs

83704

Northwest Clinical Trials, Boise

84107

Utah Clinical Trials, LLC, Salt Lake City

84405

Advanced Research Institute, Ogden

85741

Genova Clinical Research, Tucson

89128

Affiliated Clinical Research, Las Vegas

90036

Impact Clinical Trials, Los Angeles

92123

Medical Associates Research Group, San Diego

92708

Edinger Medical Group Clinical Research Center, Fountain Valley

92801

Advanced Clinical Research Institute, Anaheim

92868

Community Clinical Trials, Orange

92869

AGMG - Orange, Orange

01830

ActivMed Practice and Research, Haverhill

Sponsors
All Listed Sponsors
lead

Lexicon Pharmaceuticals

INDUSTRY